CCO Independent Conference Coverage of the AASLD Conference 2020

November 13-16, 2020; Virtual
In this downloadable slideset, CCO’s expert faculty summarize emerging data on HBV management and treatment, discuss progress on identifying risk for hepatocellular carcinoma, and examine emerging trends in HCV treatment outcomes.
Norah Terrault Headshot
Norah Terrault, MD, MPH
Format: Microsoft PowerPoint (.ppt)
File Size: 4.4 MB
Released: November 25, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Educational grant provided by
Gilead Sciences

Related Content

Clinical Care Options (CCO) expert analysis by Dr. Nancy Reau on new viral hepatitis data from AASLD 2021, including HBV, HCV, and hepatitis delta

Nancy Reau, MD Released: December 3, 2021

Complimentary slides from CCO featuring an in-depth analysis of HCV burden and care disparities in specific populations and strategies to reduce disparities.

Released: December 1, 2021

Expert insights on special considerations for individuals with HCV in ethnically diverse populations, from Ahmed M. Elsharkawy PhD, FRCP(UK), and Clinical Care Options (CCO)

person default Ahmed M. Elsharkawy, PhD, FRCP(UK) Released: December 1, 2021

Clinical Care Options (CCO) podcast with Dr. Nancy Reau on new viral hepatitis data from AASLD 2021, including HBV, HCV, and hepatitis delta

Nancy Reau, MD Released: December 1, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue